Ensoma starts its engines
Newly launched company hits the ground running with $70M in financing and a collaboration with Takeda
agreements
A margetuximab agreement for MacroGenics and EVERSANA
MacroGenics and EVERSANA announce approval-dependent agreement to support launch and commercialization of margetuximab
